AIMS/HYPOTHESIS: Glycaemic markers and fasting insulin are frequently measured outcomes of intervention studies. To extrapolate accurately the impact of interventions on the risk of diabetes incidence, we investigated the size and shape of the associations of fasting plasma glucose (FPG), 2 h post-load glucose (2hPG), HbA1c, fasting insulin and HOMA-IR with incident type 2 diabetes mellitus. METHODS: The study population included 1349 participants aged 50-75 years without diabetes at baseline (1989) from a population-based cohort in Hoorn, the Netherlands. Incident type 2 diabetes was defined by the WHO 2011 criteria or known diabetes at follow-up. Logistic regression models were used to determine the associations of the glycaemic markers, ...
Aims/hypothesis: Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) ...
Aim: To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose...
Aims/hypothesis Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) D...
Aims/hypothesis: Glycaemic markers and fasting insulin are frequently measured outcomes of intervent...
Objective: To investigate the association between changes of fasting plasma glucose (FPG) values and...
Item does not contain fulltextCONTEXT: Persons with impaired glucose tolerance (IGT) are known to ha...
International audienceOBJECTIVE: To compare incidences and risk factors for diabetes using seven def...
OBJECTIVE—To compare incidences and risk factors for diabetes using seven definitions, with combinat...
International audienceAIM: We examined the ability of fasting plasma glucose and HbA(1c) to predict ...
Objective: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) ...
International audienceINTRODUCTION: With diabetes defined by HbA1c≥6.5% and/or FPG≥7.0mmol/l and/or ...
OBJECTIVE—To investigate the association of normal fasting plasma glucose (FPG) and the risk for typ...
Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insuli...
SummaryBackgroundLittle is known about the timing of changes in glucose metabolism before occurrence...
SummaryBackgroundMost clinicians acknowledge that type 2 diabetes is multifactorial and has heteroge...
Aims/hypothesis: Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) ...
Aim: To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose...
Aims/hypothesis Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) D...
Aims/hypothesis: Glycaemic markers and fasting insulin are frequently measured outcomes of intervent...
Objective: To investigate the association between changes of fasting plasma glucose (FPG) values and...
Item does not contain fulltextCONTEXT: Persons with impaired glucose tolerance (IGT) are known to ha...
International audienceOBJECTIVE: To compare incidences and risk factors for diabetes using seven def...
OBJECTIVE—To compare incidences and risk factors for diabetes using seven definitions, with combinat...
International audienceAIM: We examined the ability of fasting plasma glucose and HbA(1c) to predict ...
Objective: To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) ...
International audienceINTRODUCTION: With diabetes defined by HbA1c≥6.5% and/or FPG≥7.0mmol/l and/or ...
OBJECTIVE—To investigate the association of normal fasting plasma glucose (FPG) and the risk for typ...
Glucose, insulin and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) are markers of insuli...
SummaryBackgroundLittle is known about the timing of changes in glucose metabolism before occurrence...
SummaryBackgroundMost clinicians acknowledge that type 2 diabetes is multifactorial and has heteroge...
Aims/hypothesis: Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) ...
Aim: To examine the hypothesis that, based on their glucose curves during a seven-point oral glucose...
Aims/hypothesis Here, we describe the characteristics of the Innovative Medicines Initiative (IMI) D...